Recent News

rss

Important Information

from the State Medical Board of Ohio

Changes to Telemedicine, Emergency Licensure and Continuing Education

 

 

The State Medical Board of Ohio met on Wednesday, March 18, 2020 and voted on the items below to better allow licensees to respond and provide essential health care during the COVID-19 pandemic. Specific motions from the meeting can be found here.

 

Telemedicine

Effective March 9, 2020 until Executive Order 2020-01D expires, providers can use telemedicine in place of in-person visits, without enforcement from SMBO. This includes, but is not limited to:

  • Prescribing controlled substances

  • Prescribing for subacute and chronic pain

  • Prescribing to patients not seen by the provider

  • Pain management

  • Medical marijuana recommendations and renewals

  • Office-based treatment for opioid addiction

Providers must document their use of telemedicine and meet minimal standards of care. The Medical Board will provide advance notice before resuming enforcement of the above regulation when the state emergency orders are lifted.

Continuing Education

  • Effective March 9, 2020 - March 1, 2021, SMBO will suspend enforcement of CE requirements for all license renewals, including physicians

  • This does NOT include any existing board orders and consent agreements for individual licensees. Those remedial education expectations must be met.

  • Licensees are reminded that this does not excuse the legal requirement for CE, the board is only suspending enforcement. Licensees who do not complete their required CE by the time of their renewal will indicate that on their license renewal and enforcement will not be taken.

Emergency Licensure

The Medical Board will partner with the Ohio Emergency Management Agency (EMA) or other necessary government entity if the need arises to temporarily license out-of-state physicians and physician assistants.

 

 

Missed any of our COVID-19 guidance or updates? They can be found on our website: https://med.ohio.gov/COVID-19



Comments are closed.

Showing 0 Comment